Podcast
Questions and Answers
Which of the following mechanisms is NOT a way that malignant tumors evade host immune responses?
Which of the following mechanisms is NOT a way that malignant tumors evade host immune responses?
How can the downregulation of class I MHC expression on tumor cells help them evade the immune system?
How can the downregulation of class I MHC expression on tumor cells help them evade the immune system?
How can the loss of expression of antigens that elicit immune responses help malignant tumors evade the immune system?
How can the loss of expression of antigens that elicit immune responses help malignant tumors evade the immune system?
What role do costimulators and class II MHC molecules play in immune response to tumors?
What role do costimulators and class II MHC molecules play in immune response to tumors?
Signup and view all the answers
How can the products of tumor cells suppress anti-tumor immune responses?
How can the products of tumor cells suppress anti-tumor immune responses?
Signup and view all the answers
Study Notes
Immune Evasion Mechanisms in Malignant Tumors
- Malignant tumors often evade or resist the host's immune system.
- Reduced Class I MHC expression: Tumor cells may downregulate Class I MHC molecules, preventing cytotoxic T lymphocytes (CTLs) from recognizing and attacking them.
- Loss of immunogenic antigens: Tumors may lose the expression of antigens that would normally trigger an immune response.
- Lack of costimulators and Class II MHC: Tumor cells often fail to express costimulators or Class II MHC molecules, hindering the activation and differentiation of CTLs.
- Immunosuppressive tumor products: Tumor cells can produce substances that suppress anti-tumor immune responses.
- Induced immunologic tolerance: Tumor antigens can sometimes induce specific immunological tolerance, making the system less able to fight the tumor.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz explores the mechanisms by which malignant tumors evade the host's immune system. Key topics include reduced Class I MHC expression, loss of immunogenic antigens, and the production of immunosuppressive substances by tumor cells. Understanding these mechanisms is crucial for developing effective cancer immunotherapies.